Physician profile
Brittany Denton
NPI 1073054979
$681.03
in general payments reported to CMS, 2019-2025
14 companies · $18.90 in 2025
The $18.90 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $257 · 2023: $25.35 · 2024: $119 · 2025: $18.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $148.18 | 2021-2024 | Repatha |
| Novo Nordisk INC | $132.16 | 2021-2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.64 | 2021-2022 | |
| Lilly USA, LLC | $67.26 | 2021-2023 | Mounjaro |
| Janssen Pharmaceuticals, INC | $61.88 | 2021-2022 | |
| Mylan Specialty L.P. | $41.81 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $39.76 | 2021-2022 | |
| Esperion Therapeutics, INC. | $19.68 | 2021 | |
| Xeris Pharmaceuticals, INC. | $19.11 | 2022 | |
| Daiichi Sankyo INC. | $16.29 | 2022 | |
| Pfizer INC. | $15.58 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.83 | 2021 | |
| Sunovion Pharmaceuticals INC. | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.